Search Results - "van Treijen, Mark J.C."

Blood Molecular Genomic Analysis Predicts the Disease Course of Gastroenteropancreatic Neuroendocrine Tumor Patients: A Validation Study of the Predictive Value of the NETest by van Treijen, Mark J C, van der Zee, Dennis, Heeres, Birthe C, Staal, Femke C R, Vriens, Menno R, Saveur, Lisette J, Verbeek, Wieke H M, Korse, Catharina M, Maas, Monique, Valk, Gerlof D, Tesselaar, Margot E T

“…Reliable prediction of disease status is a major challenge in managing gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The aim of the study was to…”
Get more information

Additional holmium-166 radioembolisation after lutetium-177-dotatate in patients with neuroendocrine tumour liver metastases (HEPAR PLuS): a single-centre, single-arm, open-label, phase 2 study by Braat, Arthur J A T, Bruijnen, Rutger C G, van Rooij, Rob, Braat, Manon N G J A, Wessels, Frank J, van Leeuwaarde, Rachel S, van Treijen, Mark J C, de Herder, Wouter W, Hofland, Johannes, Tesselaar, Margot E T, de Jong, Hugo W A M, Lam, Marnix G E H

“…In patients with metastatic neuroendocrine neoplasms, the liver is the most commonly affected organ and a crucial factor for prognosis and survival. Peptide…”
Get full text

Metastatic Patterns of Duodenopancreatic Neuroendocrine Tumors in Patients With Multiple Endocrine Neoplasia Type 1 by Hackeng, Wenzel M., van Beek, Dirk-Jan, Kok, Aranxa S.M., van Emst, Madelon, Morsink, Folkert H.M., van Treijen, Mark J.C., Borel Rinkes, Inne H.M., Dreijerink, Koen M.A., Offerhaus, G. Johan A., Valk, Gerlof D., Vriens, Menno R., Brosens, Lodewijk A.A.

“…Patients with multiple endocrine neoplasia 1 syndrome (MEN1) often develop multifocal duodenopancreatic neuroendocrine tumors (dpNETs). Nonfunctional…”
Get full text

A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor Progression by Fahrmann, Johannes F, Wasylishen, Amanda R, Pieterman, Carolina R C, Irajizad, Ehsan, Vykoukal, Jody, Murage, Eunice, Wu, Ranran, Dennison, Jennifer B, Krishna, Hansini, Peterson, Christine B, Lozano, Guillermina, Zhao, Hua, Do, Kim-Anh, Halperin, Daniel M, Agarwal, Sunita K, Blau, Jenny E, Del Rivero, Jaydira, Nilubol, Naris, Walter, Mary F, Welch, James M, Weinstein, Lee S, Vriens, Menno R, van Leeuwaarde, Rachel S, van Treijen, Mark J C, Valk, Gerlof D, Perrier, Nancy D, Hanash, Samir M

“…Duodenopancreatic neuroendocrine tumors (dpNETs) frequently occur in patients with multiple endocrine neoplasia type 1 (MEN1), and metastatic dpNET is the…”
Get full text

Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression by Fahrmann, Johannes F, Wasylishen, Amanda R, Pieterman, Carolina R C, Irajizad, Ehsan, Vykoukal, Jody, Wu, Ranran, Dennison, Jennifer B, Peterson, Christine B, Zhao, Hua, Do, Kim-Anh, Halperin, Daniel M, Agarwal, Sunita K, Blau, Jenny E, Jha, Smita, Rivero, Jaydira Del, Nilubol, Naris, Walter, Mary F, Welch, James M, Weinstein, Lee S, Vriens, Menno R, van Leeuwaarde, Rachel S, van Treijen, Mark J C, Valk, Gerlof D, Perrier, Nancy D, Hanash, Samir M, Katayama, Hiroyuki

“…Abstract Purpose Patients with multiple endocrine neoplasia type 1 (MEN1) are predisposed to develop duodenopancreatic neuroendocrine tumors (dpNETs), and…”
Get full text

Initiating Pancreatic Neuroendocrine Tumor (pNET) Screening in Young MEN1 Patients: Results From the DutchMEN Study Group by Klein Haneveld, Mirthe J, van Treijen, Mark J C, Pieterman, Carolina R C, Dekkers, Olaf M, van de Ven, Annenienke, de Herder, Wouter W, Zandee, Wouter T, Drent, Madeleine L, Bisschop, Peter H, Havekes, Bas, Vriens, Menno R, Verrijn Stuart, Annemarie A, Valk, Gerlof D, van Leeuwaarde, Rachel S

“…Nonfunctioning pancreatic neuroendocrine tumors (NF-pNETs) are highly prevalent and constitute an important cause of mortality in patients with multiple…”
Get full text

Metastatic Patterns of Duodenopancreatic Neuroendocrine Tumors in Patients With Multiple Endocrine Neoplasia Type 1 by Hackeng, Wenzel M., van Beek, Dirk-Jan, Kok, Aranxa S.M., van Emst, Madelon, Morsink, Folkert H.M., van Treijen, Mark J.C., Borel Rinkes, Inne H.M., Dreijerink, Koen M.A., Offerhaus, G. Johan A., Valk, Gerlof D., Vriens, Menno R., Brosens, Lodewijk A.A.

“…Patients with multiple endocrine neoplasia 1 syndrome (MEN1) often develop multifocal duodenopancreatic neuroendocrine tumors (dpNETs). Nonfunctional…”
Get full text

Blood Transcript Profiling for the Detection of Neuroendocrine Tumors: Results of a Large Independent Validation Study by van Treijen, Mark J C, Korse, Catharina M, van Leeuwaarde, Rachel S, Saveur, Lisette J, Vriens, Menno R, Verbeek, Wieke H M, Tesselaar, Margot E T, Valk, Gerlof D

“…Available neuroendocrine biomarkers are considered to have insufficient accuracy to discriminate patients with gastro-entero-pancreatic neuroendocrine tumors…”
Get full text

Abstract P066: Blood-based proteomic signatures associated with MEN1-related duodenopancreatic neuroendocrine tumor progression by Fahrmann, Johannes F., Wasylishen, Amanda R., Pieterman, Carolina R.C., Irajizad, Ehsan, Vykoukal, Jody, Wu, Ranran, Dennison, Jennifer D., Peterson, Christine B., Lozano, Guillermina, Zhao, Hua, Do, Kim-Ahn, Halperin, Daniel M., Agarwal, Sunita K., Blau, Jenny E., Rivero, Jaydira D., Nilubol, Naris, Walter, Mary F., Welch, James M., Weinstein, Lee S., Vriens, Menno R., Leeuwaarde, Rachel S. van, Treijen, Mark J.C. van, Valk, Gerlof D., Perrier, Nancy D., Hanash, Sam M, Katayama, Hiroyuki

“…Multiple Endocine Neoplasia Type 1 (MEN1) is associated with duodenopancreatic neuroendocrine tumors (dpNETs) and metastatic dpNET is the primary cause of…”
Get full text

The Additional Value of Somatostatin Receptor Positron Emission Computed Tomography ([ 68 Ga]Ga-DOTATOC PET/CT) Compared with Magnetic Resonance Imaging of the Head and Neck Region in Paraganglioma Patients: A Pilot Study by de Bresser, Carolijn J M, Petri, Bart-Jeroen, Braat, Arthur J A T, de Keizer, Bart, van Treijen, Mark J C, Dankbaar, Jan Willem, Pameijer, Frank A, Kok, Marius G J, de Ridder, Mischa, van Nesselrooij, Bernadette P M, de Bree, Remco, de Borst, Gert J, Rijken, Johannes A

“…The Dutch guideline for patients suspected of head and neck paragangliomas (HNPGLs) recommends magnetic resonance imaging (MRI) and/or computed tomography (CT)…”
Get full text

Diagnosing Nonfunctional Pancreatic NETs in MEN1: The Evidence Base by van Treijen, Mark J C, van Beek, Dirk-Jan, van Leeuwaarde, Rachel S, Vriens, Menno R, Valk, Gerlof D

“…Abstract In multiple endocrine neoplasia type 1 (MEN1), nonfunctional pancreatic neuroendocrine tumors (NF-pNETs) are the most frequently diagnosed NETs and a…”
Get full text

Possible pitfalls in the workup of ectopic ACTH secretion illustrated by four rare cases by Boers, Jorianne, Oldenburg-Ligtenberg, P Christine, Stades, Aline ME, van Treijen, Mark JC

“…In this case report, we highlight four different cases of ectopic adrenocorticotropic hormone (ACTH) secretion with different pitfalls in the diagnostic…”
Get full text

Gallium-68-somatostatin receptor PET/CT parameters as potential prognosticators for clinical time to progression after peptide receptor radionuclide therapy: a cohort study by Ebbers, Sander C., Heimgartner, Muriël, Barentsz, Maarten W., van Leeuwaarde, Rachel S., van Treijen, Mark J. C., Lam, Marnix M. E. G., Braat, Arthur J. A. T.

“…Background Early [ 68 Ga]Ga-DOTA-TOC PET/CT imaging after peptide receptor radionuclide therapy (PRRT) in neuroendocrine neoplasm patients is often used as a…”
Get full text